MustGrow Biologics (TSXV:MGRO) Cash And Cash Equivalents : C$3.00 Mil (As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is MustGrow Biologics Cash And Cash Equivalents?

MustGrow Biologics's quarterly cash and cash equivalents declined from Jun. 2024 (C$4.67 Mil) to Sep. 2024 (C$3.57 Mil) but then stayed the same from Sep. 2024 (C$3.57 Mil) to Dec. 2024 (C$3.00 Mil).

MustGrow Biologics's annual cash and cash equivalents declined from Dec. 2022 (C$7.02 Mil) to Dec. 2023 (C$6.82 Mil) and declined from Dec. 2023 (C$6.82 Mil) to Dec. 2024 (C$3.00 Mil).

MustGrow Biologics Cash And Cash Equivalents Historical Data

The historical data trend for MustGrow Biologics's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MustGrow Biologics Cash And Cash Equivalents Chart

MustGrow Biologics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Cash And Cash Equivalents

Get a 7-Day Free Trial

3.31

9.62

7.02

6.82

3.00

MustGrow Biologics Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Cash And Cash Equivalents	Get a 7-Day Free Trial															6.82	5.89	4.67	3.57	3.00

MustGrow Biologics Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

MustGrow Biologics (TSXV:MGRO) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

MustGrow Biologics Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of MustGrow Biologics's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

MustGrow Biologics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » MustGrow Biologics Corp (TSXV:MGRO) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

MGROF:USA 0C0:Germany

Address

1005 - 201 1st Avenue South, Saskatoon, SK, CAN, S7K 1J5

Website

https://www.mustgrow.ca

MustGrow Biologics Corp is a fully integrated provider of innovative biological and regenerative agriculture solutions designed to support sustainable farming. The Company's proprietary and third-party product lines offer eco-friendly alternatives to restricted or banned synthetic chemicals and fertilizers. It offers a portfolio of third-party crop nutrition solutions, including micronutrients, nitrogen stabilizers, biostimulants, and foliar products. These products are synergistically distributed alongside MustGrow's wholly owned proprietary products and technologies that are derived from mustard and developed into organic biocontrol and biofertility products to help replace banned or restricted synthetic chemicals and fertilizers.

Executives

Brian Quigley	Director
Colin Michael Bletsky	Director
Corey Joseph Giasson	Director, Senior Officer